HEATHER COLUMBIA-KINNEY: Open Payments
NPI 1871971424 · NEWPORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 43 payments from 12 companies in 2025. Trend: 2023 $1,886 · 2024 $1,225 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $221 |
| ABBVIE INC. | 15 | $216 |
| Axsome Therapeutics, Inc. | 3 | $88 |
| Novo Nordisk Inc | 4 | $81 |
| Astellas Pharma US Inc | 3 | $68 |
| PFIZER INC. | 2 | $43 |
| Amgen Inc. | 2 | $32 |
| Exact Sciences Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
Products named: ZEPBOUND, VRAYLAR, Auvelity, MOUNJARO, UBRELVY, Veozah, JARDIANCE, QULIPTA.
Industry payments across KY — which companies pay providers there.
